The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

QIA FINANCIAL STATEMENTS

QIAGEN NV — balance sheet, income statement and cash flow trends

QIAQIAGEN NV

🇩🇪 Germany · XETRA · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
01 B2 B202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue2.1 B $Gross Profit1.3 B $ · 62%Operating Income489.7 M $ · 23%Pre-tax Income456.2 M $ · 22%Net Income401.9 M $ · 19%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.1 B $+4.7%
Gross Profit1.3 B $+27.4%
Operating Income489.7 M $+314.6%
EBITDA797.6 M $+110.3%
Net Income401.9 M $+329.0%

Peer Comparison· Diagnostics & Research

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
QIA4.7%61.8%38.0%19.2%
Industry median9.1%53.0%18.8%6.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B6 B202120222023202420252026

Capital Structure

Q1 2026
Total Assets5.8 B
  • Equity3.3 B $58%
  • Current Liabilities477.3 M $8%
  • Long-term Liabilities2 B $34%

Key Figures

YoY change
Total Assets5.8 B $+3.9%
Total Liabilities2.4 B $+14.2%
Total Equity3.3 B $-2.6%
Cash & ST Investments643.8 M $-33.2%
Total Debt1.6 B $+16.5%
Net Debt996.5 M $+29.5%

Peer Comparison· Diagnostics & Research

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
QIA3.2149.4%1.2557.6%
Industry median1.8749.3%1.9250.1%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
0200 M400 M600 M614.8 M $Operating-214.7 M $Investing-394.1 M $Financing6.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow614.8 M $-9.6%
Capital Expenditures204.5 M $+15.4%
Free Cash Flow410.3 M $-18.4%
Dividends Paid54.2 M $—

Peer Comparison· Diagnostics & Research

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
QIA29.3%19.6%9.8%153.0%
Industry median16.3%9.7%4.5%110.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on QIA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.